Published online Jun 26, 2022. doi: 10.12998/wjcc.v10.i18.6021
Peer-review started: December 7, 2021
First decision: January 25, 2022
Revised: March 23, 2022
Accepted: April 21, 2022
Article in press: April 21, 2022
Published online: June 26, 2022
Processing time: 191 Days and 12.8 Hours
Lesions of breast imaging reporting and data system (BI-RADS) 4 at mammo
To evaluate the value of DWI and PWI in diagnosing BI-RADS 4 breast lesions.
This is a retrospective study which included patients who underwent breast MRI between May 2017 and May 2019 in the hospital. The lesions were divided into benign and malignant groups according to the classification of histopathological results. The diagnostic efficacy of DWI and PWI were analyzed respectively and combinedly. The 95 lesions were divided according to histopathological diagnosis, with 46 benign and 49 malignant. The main statistical methods used included the Student t-test, the Mann-Whitney U-test, the chi-square test or Fisher’s exact test.
The mean apparent diffusion coefficient (ADC) values in the parenchyma and lesion area of the normal mammary gland were 1.82 ± 0.22 × 10-3 mm2/s and 1.24 ± 0.16 × 10-3 mm2/s, respectively (P = 0.021). The mean ADC value of the malignant group was 1.09 ± 0.23 × 10-3 mm2/s, which was lower than that of the benign group (1.42 ± 0.68 × 10-3 mm2/s) (P = 0.016). The volume transfer constant (Ktrans) and rate constant (Kep) values were higher in malignant lesions than in benign ones (all P < 0.001), but there were no significant statistical differences regarding volume fraction (Ve) (P = 0.866). The sensitivity and specificity of PWI combined with DWI (91.7% and 89.3%, respectively) were higher than that of PWI or DWI alone. The accuracy of PWI combined with DWI in predicting pathological results was significantly higher than that predicted by PWI or DWI alone.
DWI, combined with PWI, might possibly distinguish between benign and malignant BI-RADS 4 breast lesions at mammography.
Core Tip: Lesions of breast imaging reporting and data system (BI-RADS) at mammography only appeared a wide range of risk of being malignant (2%-96%). The specificity of magnetic resonance imaging in detecting breast is relatively low. This study aimed to evaluate the value of diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) in diagnosing BI-RADS 4 breast lesions. The diagnostic efficacy of DWI and PWI were analyzed respectively and jointly. The results suggested DWI, combined with PWI, might possibly help distinguish benign breast lesions from malignant ones and provide clear diagnostic results for patients with potentially malignant BI-RADS 4 lesions at mammography.